JB/CALL/POLE GROU/21/0.125/20.09.24 Stock JB/CALL/POLE GROU/21/0.125/20.09.24
Add to a list
To use this feature you must be a member
Log inSign up

JB/CALL/POLE GROU/21/0.125/20.09.24 Share Price

Warrant

PPGSJB

CH1276780090

Market Closed - Swiss Exchange 08:50:00 31/05/2024 pm IST
1.66 CHF +7.79% Intraday chart for JB/CALL/POLE GROU/21/0.125/20.09.24
Current month+17.73%
1 month+17.73%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart POLYPEPTIDE GROUP AG
Chart JB/CALL/POLE GROU/21/0.125/20.09.24

Latest news about POLYPEPTIDE GROUP AG

PolyPeptide : and Donaldson collaborate to develop solvent recovery system for peptide purification PU
Donaldson Company, Inc. and PolyPeptide Group AG Partners to Improve Sustainability in Peptide Manufacturing with Solvent Recovery Technology CI
Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group AQ
PolyPeptide announces results of the annual General Meeting 2024 EQ
More news

Quotes 5-day view

Date Price Change
31/24/31 1.66 +7.79%
30/24/30 1.54 +3.36%
29/24/29 1.49 -7.45%
28/24/28 1.61 -0.62%
27/24/27 1.62 +4.52%

Delayed Quote Swiss Exchange

Last update May 31, 2024 at 08:50 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying POLYPEPTIDE GROUP AG
Issuer Bank Julius Bär
PPGSJB
ISINCH1276780090
Date issued 21/07/2023
Strike 21 CHF
Maturity 20/09/2024 (112 Days)
Parity 8 : 1
Emission price 0.59 CHF
Emission volume N/A
Settlement les deux
Currency CHF

Technical Indicators

Highest since issue 1.74 CHF
Lowest since issue 0.14 CHF
Delta0.9x
Omega 2.261
Premium2.75x
Gearing2.51x
Moneyness 1.590
Difference Strike -12.4 CHF
Difference Strike %-59.05%
Spread 0.01 CHF
Spread %0.60%
Theoretical value 1.665
Implied Volatility 78.88 %
Total Loss Probability 19.65 %
Intrinsic value 1.550
Present value 0.1150
Break even 34.32 CHF
Theta-0.01x
Vega0x
Rho0.01x

Company Profile

Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
More about the company

Ratings for PolyPeptide Group AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: PolyPeptide Group AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
34.09 EUR
Average target price
25.12 EUR
Spread / Average Target
-26.30%
Consensus
  1. Stock Market
  2. Warrants
  3. PPGSJB Warrant